Reinaldo de Menezes Martins

发表

Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data☆

S. Kochhar, K. Top, N. MacDonald, 2016, Vaccine.

Serious adverse events associated with yellow fever vaccine

A. Homma, Reinaldo de Menezes Martins, Maria da Luz Fernandes Leal, 2015, Human vaccines & immunotherapeutics.

Clinical and Immunological Insights on Severe, Adverse Neurotropic and Viscerotropic Disease following 17D Yellow Fever Vaccination

D. Teuwen, A. Teixeira-Carvalho, D. Silveira-Lemos, 2009, Clinical and Vaccine Immunology.

Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: case definition and guidelines for data collection, analysis, and presentation.

S. Halperin, U. Heininger, J. Bonhoeffer, 2007, Vaccine.

Duration of post-vaccination immunity to yellow fever in volunteers eight years after a dose-response study

Luiz Antonio Bastos Camacho, L. Camacho, A. Homma, 2018, Vaccine.

17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil

A. Teixeira-Carvalho, P. Tauil, O. Martins-Filho, 2019, Emerging infectious diseases.

Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody.

Ana Carolina Campi-Azevedo, Olindo Assis Martins-Filho, Renato Sathler Avelar, 2011, The Journal of infectious diseases.

Duration of post-vaccination humoral immunity against yellow fever in children.

O. Martins-Filho, A. C. Campi-Azevedo, Jandira Aparecida Campos Lemos, 2019, Vaccine.

17DD and 17D-213/77 Yellow Fever Substrains Trigger a Balanced Cytokine Profile in Primary Vaccinated Children

Luiz Antonio Bastos Camacho, Ana Carolina Campi-Azevedo, Olindo Assis Martins-Filho, 2012, PloS one.

Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in healthy Brazilian infants: a randomized non-inferiority study.

L. Camacho, M. Siqueira, A. Homma, 2015, Contemporary clinical trials.

Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals

Rodrigo Weber dos Santos, Marcelo Lobosco, Carla Rezende Barbosa Bonin, 2020, BMC Bioinformatics.